BioCentury
ARTICLE | Clinical News

Monsanto regulatory update

October 16, 1995 7:00 AM UTC

The St. Louis company's genetically engineered, delayed ripening tomato received marketing clearance from the USDA. The tomato contains a gene that expresses an enzyme to control the level of ethylene, which controls the rate of ripening. Monsanto said it has not decided when or if it will commercialize the tomato. ...